[unable to retrieve full-text content]
Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.
[unable to retrieve full-text content]
Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.
Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.